Medlab Middle East 2024 to Highlight Importance of Sustainability in Laboratories
|
By LabMedica International staff writers Posted on 23 Jan 2024 |
.jpg)
Laboratories, known for their high energy usage, typically consume tenfold more power compared to commercial office spaces. This significant consumption underscores the importance of sustainability, a key focus at the upcoming 'Sustainability in the Lab' conference during Medlab Middle East 2024. Organized by Informa Markets Healthcare (London, UK), Medlab Middle is the largest medical laboratory exhibition in the region. The conference will spotlight the need for environmentally responsible practices in the healthcare sector, with leading experts scheduled to speak at the event.
Laboratories, well known for their resource-heavy operations, use significantly more energy and water than standard commercial offices – up to ten and four times more, respectively. Additionally, labs contribute to environmental strain by generating about 5.5 million metric tons of plastic waste yearly. Recognizing these challenges, many labs and pharmaceutical companies are proactively adopting measures to reduce their environmental footprint. The ‘Sustainability in the Laboratory’ conference at Medlab Middle East aims to bring this critical issue to the forefront. Scheduled for 8 February at the Medlab Middle East Congress, this CME Accredited event will convene experts from the UAE, US, UK, and Germany. These professionals will discuss their experiences and strategies for fostering eco-friendly initiatives in labs, enlightening attendees on sustainable practices that not only enhance operational efficiency but also mitigate environmental impact. Implementing these practices can lead to significant gains, including waste reduction and increased productivity.
Despite the lack of formal guidelines, laboratories can still make impactful changes, such as switching off idle lights and equipment and transitioning to energy-efficient LED lighting. Regular maintenance of equipment, using taps over pure water, and proper waste segregation are vital steps. The heavy reliance of labs on plastic items, like gloves, tubes, and single-use pipette tips, makes plastic recycling and reuse programs crucial for waste reduction. Additionally, laboratories can adopt ACT labels – which are akin to eco-nutrition labels for lab products – that outline the Accountability, Consistency, and Transparency in production, energy and water consumption, and end-of-life disposal for laboratory items.
Dr. Nehmat El Banna, Clinical Pathology Specialist and CEO of Freiburg Medical (Dubai, UAE), who will be speaking at the ‘Sustainability in the Laboratory’ conference believes that the topic is a crucial part of the healthcare system in general. Since the last five years, Freiburg Medical has continued to implement sustainable practices across its facility in the UAE such as the use of energy-efficient LED lighting, reduction of water usage, and utilization of instruments that are more environmentally friendly. In addition, the company works closely with its suppliers to ensure the adoption of sustainable practices.
“Laboratories are a significant player in the healthcare industry and are known to be the highest users of energy in the sector,” said Dr. Nehmat El Banna. “Climate change has a direct consequence on human health. There will be higher temperatures, more adverse weather events, and poorer air quality which leads to more illnesses, and infectious diseases will spread more easily. All of this will place a greater burden on the healthcare industry. While climate change is a complex issue with many contributing factors, the health of future generations is of paramount importance to us as a sector. We must, therefore, address the environmental footprint of laboratories and take action to mitigate the effects of our operations.”
“As the region’s largest medical laboratory exhibition and congress, sustainability has become a paramount focus for Medlab Middle East,” added Tom Coleman, Exhibition Director, Informa Markets Healthcare, who agrees that even small initiatives can make a difference. “Even small conservation efforts can lead to significant environmental and cost benefits for laboratories, this is why laboratory sustainability is becoming a top priority.”
Related Links:
Informa Markets Healthcare
Freiburg Medical
Latest Industry News
- AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
- New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
- Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
- WHX Labs Dubai to Gather Global Experts in Antimicrobial Resistance at Inaugural AMR Leaders’ Summit
- BD and Penn Institute Collaborate to Advance Immunotherapy through Flow Cytometry
- Abbott Acquires Cancer-Screening Company Exact Sciences
- Roche and Freenome Collaborate to Develop Cancer Screening Tests
- Co-Diagnostics Forms New Business Unit to Develop AI-Powered Diagnostics
- Qiagen Acquires Single-Cell Omics Firm Parse Biosciences
- Puritan Medical Products Showcasing Innovation at AMP2025 in Boston
- Advanced Instruments Merged Under Nova Biomedical Name
- Bio-Rad and Biodesix Partner to Develop Droplet Digital PCR High Complexity Assays
- Hologic to be Acquired by Blackstone and TPG
- Bio-Techne and Oxford Nanopore to Accelerate Development of Genetics Portfolio
- Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders
- Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more







